NDC 49288-0071
Bay Leaf
Bay Leaf
Bay Leaf is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Laurus Nobilis.
| Product ID | 49288-0071_1d11d7ba-8b48-401c-a02e-42b54abb4296 |
| NDC | 49288-0071 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bay Leaf |
| Generic Name | Bay Leaf |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | LAURUS NOBILIS |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0071-5
50 mL in 1 VIAL, MULTI-DOSE (49288-0071-5)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0071-2 [49288007102]
Bay Leaf INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0071-5 [49288007105]
Bay Leaf INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0071-3 [49288007103]
Bay Leaf INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0071-4 [49288007104]
Bay Leaf INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0071-1 [49288007101]
Bay Leaf INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LAURUS NOBILIS | .05 g/mL |
OpenFDA Data
NDC Crossover Matching brand name "Bay Leaf" or generic name "Bay Leaf"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1666 | Bay Leaf | Bay Leaf |
| 36987-1667 | Bay Leaf | Bay Leaf |
| 36987-1668 | Bay Leaf | Bay Leaf |
| 36987-1669 | Bay Leaf | Bay Leaf |
| 49288-0071 | Bay Leaf | Bay Leaf |
Trademark Results [Bay Leaf]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BAY LEAF 86863359 not registered Dead/Abandoned |
ARORA KAMAL 2015-12-31 |
 BAY LEAF 85819569 4641766 Live/Registered |
FIOR DI SOLE, LLC 2013-01-09 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.